Physician profile
Amon T Ferry
NPI 1669639613
$482,158.56
in general payments reported to CMS, 2019-2025
18 companies · $6,217 in 2025
The $6,217 reported for 2025 was more than what 83% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154K · 2020: $53K · 2021: $68K · 2022: $89K · 2023: $37K · 2024: $74K · 2025: $6,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $103K · Travel and Lodging: $9,503 · Food and Beverage: $3,362 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $103,142.67 |
| Travel and Lodging | $9,503.17 |
| Food and Beverage | $3,361.58 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $322,755.32 | 2019-2025 | Biolox Delta, N/A, Exparel |
| Zimmer Biomet Holdings, INC. | $110,566.69 | 2019-2023 | Juggerknotless Soft Anchor |
| Depuy Synthes Products, INC. | $33,954.83 | 2019-2024 | Gryphon Orthocord, N/A, Exparel |
| Synthes Gmbh | $5,357.01 | 2022-2023 | |
| Baudax Bio INC. | $2,006.36 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $2,000.00 | 2021 | |
| Depuy Synthes Sales INC. | $1,338.06 | 2019-2025 | Truespan Orthocord, Healix Knotless Peek, Dynacord |
| Arthrex, INC. | $1,214.11 | 2024 | Arthrex |
| Pacira Therapeutics, INC. | $1,189.23 | 2019 | |
| Impactortho, INC. | $578.87 | 2022-2024 | |
| Linvatec Corporation | $397.40 | 2023 | Biobrace 23mm |
| Anika Therapeutics, INC. | $316.40 | 2019-2020 | |
| Davol INC. | $212.26 | 2019-2022 | |
| Xiros INC | $120.13 | 2022 | |
| Biorez, INC. | $70.70 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $30.63 | 2021 | |
| Abbott Laboratories | $30.44 | 2023-2024 | Proclaim |
| Mallinckrodt Enterprises LLC | $20.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amon Ferry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.